Free Trial

BioLargo (NASDAQ:BLGO) Trading Up 1.6% - Should You Buy?

BioLargo logo with Construction background

Key Points

  • BioLargo, Inc. stock increased by 1.6%, closing at $0.18 with a trading volume of 521,041 shares, a significant rise from its average daily volume.
  • The company has a market cap of $54.96 million and a negative PE ratio of -17.90, indicating potential for investors to consider.
  • BioLargo develops technologies focused on solving environmental challenges, including PFAS water contamination and advanced wastewater treatment.
  • Five stocks to consider instead of BioLargo.

BioLargo, Inc. (NASDAQ:BLGO - Get Free Report) was up 1.6% on Thursday . The company traded as high as $0.18 and last traded at $0.18. Approximately 521,041 shares traded hands during trading, an increase of 65% from the average daily volume of 315,364 shares. The stock had previously closed at $0.18.

BioLargo Stock Up 0.5%

The stock's 50 day simple moving average is $0.20 and its two-hundred day simple moving average is $0.23. The firm has a market cap of $55.23 million, a P/E ratio of -17.99 and a beta of 0.11. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.31 and a quick ratio of 2.24.

BioLargo Company Profile

(Get Free Report)

BioLargo, Inc invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation.

See Also

Should You Invest $1,000 in BioLargo Right Now?

Before you consider BioLargo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioLargo wasn't on the list.

While BioLargo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines